Targeting IgE antibodies by immunoadsorption in atopic dermatitis

Michael Kasperkiewicz*, Enno Schmidt, Ralf J. Ludwig, Detlef Zillikens

*Corresponding author for this work


One major hallmark of atopic dermatitis (AD) is the elevated level of total serum IgE, which has been reported to be partly of the autoreactive type in a subset of patients. Immunoadsorption (IA) has been successfully applied in various classical autoantibody-mediated diseases such as pemphigus. Recent reports proposed the use of IA also for patients with severe AD and high total serum IgE levels. In this mini-review, we summarize the current knowledge about this novel treatment approach for AD and briefly discuss the so far incompletely known role of autoreactive IgE as potential target of IA therapy in this common inflammatory skin disorder.

Original languageEnglish
Article number254
JournalFrontiers in Immunology
Issue numberFEB
Number of pages5
Publication statusPublished - 19.02.2018


Dive into the research topics of 'Targeting IgE antibodies by immunoadsorption in atopic dermatitis'. Together they form a unique fingerprint.

Cite this